首页|中医药调控TGF-β1/Smad信号通路防治肝纤维化的研究概况

中医药调控TGF-β1/Smad信号通路防治肝纤维化的研究概况

扫码查看
肝纤维化是多种慢性肝病进展为肝硬化、肝癌等恶性肝病极其重要的病理过程,肝硬化和肝癌是不可逆的,而肝纤维化却具有不完全可逆性.目前,国内外对肝纤维化的治疗主要是以去除致病因素或对症治疗为主,尚缺乏特异性治疗药物.中医药通过抑制TGF-β1/Smad信号通路的转导,可有效拮抗肝纤维化的发生发展.该综述通过筛选近五年的相关实验研究文献,从TGF-β1/Smad信号通路在肝纤维化中的作用、中医对肝纤维化的认识以及中医药靶向调控TGF-β1/Smad信号通路防治肝纤维化的研究三个方面进行了归纳总结,为该领域研究人员提供中医药思路.
Research Progress of Traditional Chinese Medicine Regulating TGF-β1/Smad Signaling Pathway in the Prevention and Treatment of Hepatic Fibrosis
Liver fibrosis is an extremely important pathological process in the progression of various chronic liver diseases to malignant liver diseases such as cirrhosis and liver cancer.Liver cirrhosis and liver cancer are irreversible,but liver fibrosis is not completely reversible.At present,the treatment of liver fibrosis at home and abroad is mainly based on removal of pathogenic factors or symptomatic treatment,and there is still a lack of specific therapeutic drugs.Traditional Chinese medicine can effectively antagonize the occurrence and development of liver fibrosis by inhibiting the transduction of the TGF-β1/Smad signaling pathway.This review screened relevant experimental research litera-ture in the past five years,focusing on the role of TGF-β1/Smad signaling pathway in liver fibrosis,traditional Chinese medicine's understanding of liver fibrosis,and traditional Chinese medicine's targeted regulation of TGF-β1/Smad signaling pathway for prevention and treatment.Three aspects of research on liver fibrosis are summarized to provide researchers in this field with ideas on traditional Chinese medicine.

Traditional Chinese medicineTGF-β1/Smad signaling pathwayLiver fibrosisExtracellular matrixHepatic stellate cells

周会霞、卢雨蓓

展开 >

甘肃中医药大学 甘肃兰州 730000

甘肃省中医院 甘肃兰州 730050

中医药 TGF-β1/Smad信号通路 肝纤维化 细胞外基质 肝星状细胞

2024

中医药临床杂志
中华中医药学会

中医药临床杂志

影响因子:0.636
ISSN:1672-7134
年,卷(期):2024.36(1)
  • 39